Annual Drug Patent Expirations for BORTEZOMIB Bortezomib is a drug marketed by Accord Hlthcare, Apotex, Baxter Hlthcare Corp, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hetero Labs Ltd Vi, Hospira, Jiangsu Hansoh Pharm, Meitheal, MSN, Mylan Labs Ltd,…
Annual Drug Patent Expirations for PEDMARK Pedmark is a drug marketed by Fennec Pharms Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. This drug has thirty-six patent family members in thi…
Annual Drug Patent Expirations for EPSOLAY Epsolay is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug. This drug has twenty-eight patent family members in el…
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug pat…
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in Japan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. For a global perspective, see the Drug companies with the…
Which pharmaceutical companies have the most drug patents in Japan? Read Post »
When it comes to the $200 billion global pharmaceutical manufacturing market, the real unsung heroes are the excipients – the inactive ingredients that give tablets their form, stability and controlled release properties. While the active drug ge…
Top 10 Excipients Powering the Tablet Manufacturing Industry Read Post »
This chart shows the pharmaceutical companies with the most patents in Ecuador. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. For a global perspective, see the Drug companies with t…
Which pharmaceutical companies have the most drug patents in Ecuador? Read Post »
In the ever-evolving landscape of pharmaceutical formulations, the pursuit of excipient-free products has gained significant traction. Excipients, the inactive ingredients added to medications alongside the active pharmaceutical ingredients (APIs), hav…
The Quest for Excipient-Free Formulations: Challenges and Opportunities Read Post »
In the ever-evolving landscape of pharmaceutical manufacturing, excipients – the inactive ingredients in drug formulations – play a crucial role in ensuring product quality and patient safety. While often overlooked, these seemingly innocuous component…
Ensuring Patient Safety: A Comprehensive Guide to Excipient Risk Assessments Read Post »
In the ever-evolving landscape of pharmaceutical innovation, controlled release formulations have emerged as a game-changer, offering patients enhanced therapeutic benefits and improved medication adherence. However, the success of these advanced drug …
Excipients: The Unsung Heroes of Controlled Release Formulations Read Post »
Get new actionable insights and updates from BiotechBlog
